SCHEDULE 13G/A: Patient Capital Management Discloses Significant Stake in Canada Goose Holdings

Patient Capital Management, LLC and Patient Opportunity Trust have filed an amended Schedule 13G, disclosing beneficial ownership of 8.42% and 6.33% respectively, in Canada Goose Holdings Inc. as of December 31, 2024.

Summary

• Patient Capital Management, LLC reported beneficial ownership of 3,807,448 shares of Canada Goose Holdings Inc. common stock, representing 8.42% of the class.
• Patient Opportunity Trust, a series of Advisor Managed Portfolios, reported beneficial ownership of 2,900,000 shares of Canada Goose Holdings Inc. common stock, representing 6.33% of the class.
• Both reporting entities are organized in Delaware, with Patient Capital Management, LLC identified as an investment adviser and Patient Opportunity Trust as an investment company.
• The filing is an Amendment No. 1 to a previous Schedule 13G, indicating an update to their beneficial ownership position.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Canada Goose Holdings Inc.

Sentiment

Score: 6

Explanation: The filing is largely neutral as a regulatory disclosure, but the continued or increased institutional ownership by Patient Capital Management and Patient Opportunity Trust can be viewed as a positive signal of investor confidence in Canada Goose Holdings Inc.

Positives

• The continued significant institutional ownership by Patient Capital Management, LLC and Patient Opportunity Trust may signal ongoing investor confidence in Canada Goose Holdings Inc.
• The passive nature of the investment, as certified by the reporting persons, suggests stability and no immediate intent to influence corporate control.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Canada Goose Holdings Inc.'s future outlook.

Industry Context

The filing indicates continued institutional investor interest in Canada Goose Holdings Inc., a prominent player in the luxury apparel and outerwear market. Such routine filings reflect investment firms' portfolio adjustments and confidence in specific companies within the consumer discretionary sector.

Comparison to Industry Standards

• This document is a beneficial ownership disclosure and does not provide financial results or operational metrics that can be directly compared to industry standards or specific comparable companies/projects. It solely reports the ownership stake of certain investment entities.

Stakeholder Impact

• Shareholders: The disclosure of significant institutional ownership can influence investor perception and potentially market liquidity for Canada Goose Holdings Inc. shares.

Next Steps

• This filing does not specify any future actions, events, or milestones for Canada Goose Holdings Inc. or the reporting entities beyond the ongoing management of their investment portfolios.

Key Dates

Keywords

Canada Goose Holdings Inc., GOOS, Patient Capital Management, Patient Opportunity Trust, SEC Filing, Schedule 13G, Beneficial Ownership, Institutional Investment, Common Stock, Apparel Industry